GLP-1s may be suitable for individuals with a BMI of 30+, or 27+ with obesity-related conditions, who prefer a non-surgical approach
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with FDA-approved indications that vary by brand name: Ozempic and Rybelsus are approved for type 2 diabetes mellitus, while Wegovy is approved for chronic weight management
When a panel convening July 23 and July 24, 2026, weighs in on whether the FDA should loosen restrictions on seven peptides, melanotan II wont be on the list
Metabolism of thiolesters of glutathione [PMID: 13107746] Laboratory literature summary: Metabolism of thiolesters of glutathione
He is a Fellow of the American College of Cardiology, an Assistant Clinical Professor of Medicine at the University of Connecticut School of Medicine, and a former chief of cardiology and medical education at Manchester (Connecticut) Memorial Hospital